XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Noncontrolling Interest
Balance, shares at Dec. 31, 2021   19,695,532      
Balance, amount at Dec. 31, 2021 $ 2,867,660 $ 19,696 $ 6,321,428 $ (3,459,214) $ (14,250)
Warrant valuation expense 437,375 0 437,375 0 0
Offering costs (16,000) 0 (16,000) 0 0
Net loss attributable to non-controlling interests (233) 0 0 0 (233)
Net loss for the months ended March 31, 2022 (876,983) $ 0 0 (876,983) 0
Balance, shares at Mar. 31, 2022   19,695,532      
Balance, amount at Mar. 31, 2022 2,411,819 $ 19,696 6,742,803 (4,336,197) (14,483)
Balance, shares at Dec. 31, 2022   23,436,505      
Balance, amount at Dec. 31, 2022 7,560,198 $ 23,436 18,095,184 (10,463,048) (95,374)
Net loss attributable to non-controlling interests 0 0 0 12,982 (12,982)
Net loss for the months ended March 31, 2022 (2,378,582) $ 0 0 (2,378,582) 0
Issuance of common stock, shares   4,830,000      
Issuance of common stock, amount 7,245,000 $ 4,830 7,240,170 0 0
Offering costs (634,600) $ 0 (634,600) 0 0
Shares issued for consulting services, shares   15,000      
Shares issued for consulting services, amount 12,900 $ 15 12,885 0 0
Capitalized value of warrants 374,453 $ 0 374,453 0 0
Balance, shares at Mar. 31, 2023   28,281,505      
Balance, amount at Mar. 31, 2023 $ 12,179,369 $ 28,281 $ 25,088,092 $ (12,828,648) $ (108,356)